Not applicableStudy completedNCT02285361What this trial is testingGIOTRIF rPMS in Korean Patients With NSCLCWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 1,272
Early research (Phase 1)Looking for participantsNCT06116786What this trial is testingJNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-small-Cell Lung Johnson & Johnson Enterprise Innovation Inc. 126
Not applicableLooking for participantsNCT07143045What this trial is testingA Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) MetastasesWho this might be right forEGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases Alpha Biopharma (Jiangsu) Co., Ltd. 800
Large-scale testing (Phase 3)Study completedNCT02864251What this trial is testingNivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) TherapyWho this might be right forNon-Small-Cell Lung Carcinoma Bristol-Myers Squibb 367
Early research (Phase 1)Looking for participantsNCT06400472What this trial is testingLY4170156 in Participants With Selected Advanced Solid TumorsWho this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more Eli Lilly and Company 495
Early research (Phase 1)Study completedNCT01976741What this trial is testingDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)Who this might be right forNeoplasms Bayer 168
Testing effectiveness (Phase 2)Looking for participantsNCT06456359What this trial is testingPasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell TumorWho this might be right forDesmoplastic Small Round Cell TumorSynovial Sarcoma University Hospital Heidelberg 28
Early research (Phase 1)Active Not RecruitingNCT03774654What this trial is testingCD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)Who this might be right forRefractory B-Cell Non-Hodgkin LymphomaRefractory B-Cell Small Lymphocytic LymphomaRelapsed Adult ALL+2 more Baylor College of Medicine 13
Post-approval studies (Phase 4)Study completedNCT01609543What this trial is testingTarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR MutationsWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 62
Testing effectiveness (Phase 2)Looking for participantsNCT05334277What this trial is testingFurmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNAWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 280
Not applicableStudy completedNCT02623257What this trial is testingEGFR Mutations on ctDNA in Patients With Advanced NSCLCWho this might be right forNon-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic First People's Hospital of Hangzhou 1,055
Not applicableUnknownNCT00815971What this trial is testingMutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With ErlotinibWho this might be right forNon-Small Cell Lung Cancer Aarhus University Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT05636267What this trial is testingStudy of AK119 and AK112 With or Without Chemotherapy for NSCLC PatientsWho this might be right forNSCLC Akeso 59
Testing effectiveness (Phase 2)WithdrawnNCT02538432What this trial is testingPhase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid TumorsWho this might be right forProstate CancerNon-Small Cell Lung CancerBreast Cancer University of Maryland, Baltimore
Testing effectiveness (Phase 2)WithdrawnNCT02355431What this trial is testingItacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsWho this might be right forSolid Tumors and Hematologic MalignancyNSCLC (Non-small Cell Lung Carcinoma) Incyte Corporation
Not applicableUnknownNCT02755337What this trial is testingThe Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine KinaseWho this might be right forNon-Small-Cell Lung Cancer Dr. Soetomo General Hospital 70
Early research (Phase 1)Active Not RecruitingNCT04042701What this trial is testingDS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung CancerWho this might be right forBreast CancerNon-small Cell Lung Carcinoma Daiichi Sankyo 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07343479What this trial is testingSacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain MetastasesWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)EGFR Gene MutationsBrain Metastasis Zhejiang Cancer Hospital 45
Not applicableStudy completedNCT01185314What this trial is testingTo Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung Cancer AstraZeneca 1,270
Large-scale testing (Phase 3)UnknownNCT05104281What this trial is testingOsimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Qingdao Central Hospital 60